UBS ASSET MANAGEMENT AMERICAS INC - AURINIA PHARMACEUTICALS INC ownership

AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 186 filers reported holding AURINIA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS ASSET MANAGEMENT AMERICAS INC ownership history of AURINIA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,147,636
-29.6%
147,701
-0.6%
0.00%0.0%
Q2 2023$1,629,2700.0%148,6560.0%0.00%0.0%
Q1 2023$1,629,270
+164.9%
148,656
+4.4%
0.00%
Q4 2022$615,077
-99.9%
142,379
+56.8%
0.00%
Q3 2022$682,891,000
-31.9%
90,810
-9.0%
0.00%
-100.0%
Q2 2022$1,003,392,000
+53.7%
99,840
+89.3%
0.00%
Q1 2022$652,921,000
-66.9%
52,740
-62.7%
0.00%
-100.0%
Q4 2021$1,970,072,000
+624.9%
141,459
+1051.9%
0.00%
Q3 2021$271,779,000
-85.2%
12,281
-91.3%
0.00%
-100.0%
Q2 2021$1,835,779,000
+17.5%
141,459
+17.7%
0.00%0.0%
Q1 2021$1,562,157,000
+1.2%
120,159
+7.3%
0.00%0.0%
Q4 2020$1,543,171,000
+5.9%
111,959
+12.8%
0.00%0.0%
Q3 2020$1,457,211,000
+13.5%
99,259
+25.1%
0.00%0.0%
Q2 2020$1,284,194,000
+21.8%
79,359
+8.0%
0.00%0.0%
Q1 2020$1,054,391,000
-5.9%
73,459
+32.9%
0.00%0.0%
Q4 2019$1,120,308,000
+1174.7%
55,259
+235.7%
0.00%
Q3 2019$87,889,000
-0.1%
16,459
+23.8%
0.00%
Q2 2019$87,937,00013,3000.00%
Other shareholders
AURINIA PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Blackcrane Capital, LLC 111,608$2,470,0003.15%
ACT CAPITAL MANAGEMENT, LLC 180,000$3,983,0002.06%
IRONWOOD INVESTMENT MANAGEMENT LLC 167,889$3,715,0001.92%
DG Capital Management, LLC 402,200$8,901,0001.81%
NEA Management Company, LLC 5,172,683$114,471,0001.36%
KESTRA PRIVATE WEALTH SERVICES, LLC 801,100$17,728,0000.99%
Altium Capital Management LP 144,000$3,187,0000.84%
HighMark Wealth Management LLC 50,569$1,119,0000.82%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 123,500$2,724,0000.66%
SEVEN EIGHT CAPITAL, LP 288,840$6,392,0000.62%
View complete list of AURINIA PHARMACEUTICALS INC shareholders